Localization of BCR-ABL to Stress Granules Contributes to Its Oncogenic FunctionSayaka Kashiwagi, Yusuke Ohba, Yoichiro Fujioka et al.|Cell Structure and Function|2019Cited by 21
Improved FRET Biosensor for the Measurement of BCR-ABL Activity in Chronic Myeloid Leukemia CellsMika Horiguchi, Yusuke Ohba, Yoichiro Fujioka et al.|Cell Structure and Function|2016Cited by 5
Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity testTakanori Teshima, Shinichi Fujisawa, Kaori Sato et al.|International Journal of Hematology|2019Cited by 5
Leukemogenic kinase <scp>FIP</scp>1L1‐<scp>PDGFRA</scp> and a small ubiquitin‐like modifier E3 ligase, <scp>PIAS</scp>1, form a positive cross‐talk through their enzymatic activitiesMakoto Ibata, Takeshi Kondo, Junko Iwasaki et al.|Cancer Science|2016Cited by 4
Localization of BCR-ABL to stress granules contributes to its oncogenic functionSayaka Kashiwagi, Yusuke Ohba, Yoichiro Fujioka et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 4